Treatment with IP-10 induces host-protective immune response by regulating the T regulatory cell functioning in Leishmania donovani-infected mice

Medical Microbiology and Immunology

Volumn 200, Issue 4, 2011, Pages 241-253

  Gupta, Gaurav ^a   Majumdar, Saikat ^a   Adhikari, Anupam ^a   Bhattacharya, Parna ^a   Mukherjee, Asok Kumar ^a   Majumdar, Suchandra Bhattacharyya ^a   Majumdar, Subrata ^a  

^a BOSE INSTITUTE   (India)

Author keywords

Chemokine; IP 10; TGF ; Tregulatory cell; Visceral leishmaniasis

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; HOST RESISTANCE; IMMUNOMODULATION; IMMUNOREACTIVITY; IMMUNOREGULATION; IN VIVO STUDY; INFECTION PREVENTION; LEISHMANIA DONOVANI; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH1 CELL; VISCERAL LEISHMANIASIS;

ANIMALS; ANTIPROTOZOAL AGENTS; BENZAMIDES; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CXCL10; COCULTURE TECHNIQUES; CYTOKINES; DIOXOLES; FLOW CYTOMETRY; IMMUNITY, CELLULAR; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MICE; MICE, INBRED BALB C; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMAD4 PROTEIN; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY;

EID: 83055188455     PISSN: 03008584     EISSN: 14321831     Source Type: Journal    
DOI: 10.1007/s00430-011-0197-y     Document Type: Article

References (55)

1. Stanley A, Engwerda C (2007) Balancing immunity and pathology in visceral leishmaniasis. Immunol Cell Biol 85:138-147
2. Kaye P, Svensson M, Ato M, Maroof A, Polley R, Stager S, Zubairi S, Engwerda C (2004) The immunopathology of experimental visceral leishmaniasis. Immunol Rev 201:239-253
3. Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, Peeling R, Alvar J, Boelaert M (2007) Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol 5:873-882
4. Croft S, Sundar S, Fairlamb A (2006) Drug resistance in leishmaniasis. Clin Microbiol Rev 19:111-126
5. Badolato R, Sacks D, Savoia D, Musso T (1996) Leishmania major: Infection of human monocytes induces expression of IL-8 and MCAF. Exp Parasitol 82:21-26
6. Racoosin E, Beverley S (1997) Leishmania major: Promastigotes induce expression of a subset of chemokine genes in murine macrophages. Exp Parasitol 85:283-295
7. Baggiolini M, Dewald B, Moser B (1997) Human chemokines: An update. Annu Rev Immunol 15:675-705
8. Bonecchi R, Bianchi G, Bordignon P, D'Ambrosio D, Lang R, Borsatti A, Sozzani S, Allavena P, Gray P, Mantovani A, Sinigaglia F (1998) DiVerential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 187:129-1341
9. Robertson M (2002) Role of chemokines in the biology of natural killer cells. J Leukoc Biol 71:173-183
10. Enderlin M, Kleinmann E, Struyf S, Buracchi C, Vecchi A, Kinscherf R, Kiessling F, Paschek S, Sozzani S, Rommelaere J, Cornelis J, Van Damme J, Dinsart C (2009) TNF-alpha and the IFN-gamma-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor eVects in mouse glioblastoma. Cancer Gene Ther 16:149-160
11. Weinzierl AO, Szalay G, Wolburg H, Sauter M, Rammensee HG, Kandolf R, StevanoviT S, Klingel K (2008) EVective chemokine secretion by dendritic cells and expansion of cross-presenting CD4/CD8+ dendritic cells deWne a protective phenotype in the mouse model of coxsackievirus myocarditis. J Virol 82:8149-8160
12. Uicker W, Doyle H, McCracken J, Langlois M, Buchanan K (2005) Cytokine and chemokine expression in the central nervous system associated with protective cell-mediated immunity against Cryptococcus neoformans. Med Mycol 43:27-38
13. Müller K, van Zandbergen G, Hansen B, Laufs H, Jahnke N, Solbach W, Laskay T (2001) Chemokines, natural killer cells and granulocytes in the early course of Leishmania major infection in mice. Med Microbiol Immunol 190:73-76
14. Dey R, Majumder N, Bhattacharyya Majumdar S, Bhattacharjee S, Banerjee S, Roy S, Majumdar S (2007) Induction of host protective Th1 immune response by chemokines in L. donovani-infected BALB/c mice. Scand J Immunol 66:671-683
15. Gupta G, Bhattacharjee S, Bhattacharyya S, Bhattacharya P, Adhikari A, Mukherjee A, Bhattacharyya Majumdar S, Majumdar S (2009) CXC chemokine-mediated protection against visceral leishmaniasis: Involvement of the proinXammatory response. J Infect Dis 200:1300-1310
16. Heller E, Liu E, Tager A, Yuan Q, Lin A, Ahluwalia N, Jones K, Koehn S, Lok V, Aikawa E, Moore K, Luster A, Gerszten R (2006) Chemokine CXCL10 promotes atherogenesis by modulating the local balance of eVector and regulatory T cells. Circulation 113:2301-2312
17. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151-11641
18. Khattri R, Cox T, Yasayko S, Ramsdell F (2003) An essential role for ScurWn in CD4+CD25+ T regulatory cells. Nat Immunol 4:337-342
19. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S (2002) Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 3:135-142
20. Read S, Malmström V, Powrie F (2000) Cytotoxic T lymphocyteassociated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inXammation. J Exp Med 192:295-302
21. Cabrera R, Tu Z, Xu Y, Firpi R, Rosen H, Liu C, Nelson D (2004) An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40:1062-1071
22. Zhong Y, Cantwell A, Dube P (2010) Transforming growth factor beta and CD25 are important for controlling systemic dissemination following Y. enterocolitica infection of the gut. Infect Immun 78:3716-3725
23. Nakamura K, Kitani A, Fuss I, Pedersen A, Harada N, Nawata H, Strober W (2004) TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J Immunol 172:834-842
24. Mendez S, Reckling S, Piccirillo C, Sacks D, Belkaid Y (2004) Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J Exp Med 200:201-210
25. Bodas M, Jain N, Awasthi A, Martin S, Penke Loka R, Dandekar D, Mitra D, Saha B (2006) Inhibition of IL-2 induced IL-10 production as a principle of phase-speciWc immunotherapy. J Immunol 177:4636-4643
26. Belkaid Y (2007) Regulatory T cells and infection: A dangerous necessity. Nat Rev Immunol 7:875-888
27. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL (2002) CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420:502-507
28. SuYa I, Reckling SK, Salay G, Belkaid Y (2005) A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection. J Immunol 174:5444-5455
29. Nylén S, Maurya R, Eidsmo L, Manandhar KD, Sundar S, Sacks D (2007) Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+(Foxp3) regulatory T cells in human visceral leishmaniasis. J Exp Med 204:805-817
30. Anderson C, Oukka M, Kuchroo V, Sacks D (2007) CD4(+)CD25()Foxp3() Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med 204:285-297
31. Nagase H, Jones KM, Anderson CF, Noben-Trauth N (2007) Despite increased CD4+Foxp3+ cells within the infection site, BALB/c IL-4 receptor-deWcient mice reveal CD4+Foxp3 T cells as a source of IL-10 in Leishmania major susceptibility. J Immunol 179:2435-24441
32. Stäger S, Maroof A, Zubairi S, Sanos S, Kopf M, Kaye P (2006) Distinct roles for IL-6 and IL-12p40 in mediating protection against L. donovani and the expansion of IL-10+CD4+ T cells. Eur J Immunol 36:1764-1771
33. Rodrigues O, Marques C, Soares-Clemente M, Ferronha M, Santos- Gomes G (2009) IdentiWcation of regulatory T cells during experimental Leishmania infantum infection. Immunobiology 214:101-111
34. Li M, Wan Y, Flavell R (2007) T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell diVerentiation. Immunity 26:579-591
35. Bommireddy R, Doetschman T (2007) TGFbeta1 and Treg cells: Alliance for tolerance. Trends Mol Med 13:492-501
36. Fantini M, Becker C, Monteleone G, Pallone F, Galle P, Neurath M (2004) Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25 T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 172:5149-5153
37. Roelen B, Cohen O, Raychowdhury M, Chadee D, Zhang Y, Kyriakis J, Alessandrini A, Lin H (2003) Phosphorylation of threonine 276 in Smad4 is involved in transforming growth factorbeta- induced nuclear accumulation. Am J Physiol Cell Physiol 285:C823-C830
38. Hart TD, Vickerman K, Coombs GH, Quick A (1981) Simple method for purifying L. mexicana amastigotes in large numbers. Parasitology 82:345-355
39. Murray HW, Miralles GD, Stoeckle MY, McDermott DF (1993) Role and eVect of IL-12 in experimental visceral leishmaniasis. J Immunol 151:929-938
40. Majumdar S, Kane LH, Rossi MW, Volpp BD, Nauseef WM, Korchak HM (1993) Protein kinase C isotypes and signal transduction in human neutrophils: Selective substrate speciWcity of calcium dependent b-PKC and novel calcium independent n-PKC. Biochim Biophys Acta 1176:276-286
41. Ghosh S, Bhattacharyya S, Sirkar M, Sa GS, Das T, Majumdar D, Roy S, Majumdar S (2002) L. donovani suppresses activated protein 1 and NF-kappaB activation in host macrophages via ceramide generation: Involvement of extracellular signal-regulated kinase. Infect Immun 70:6828-6838
42. Inman GJ, Nicolás FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ, Hill CS (2002) SB-431542 is a potent and speciWc inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, 5, and 7. Mol Pharmacol 62:65-741
43. Yurchenko E, Tritt M, Hay V, Shevach EM, Belkaid Y, Piccirillo CA (2006) CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence. J Exp Med 203:2451-2460
44. Reiner SL, Locksley RM (1995) The regulation of immunity to Leishmania major. Annu Rev Immunol 13:151-177
45. Szczepanski MJ, Szajnik M, Czystowska M, Mandapathil M, Strauss L, Welsh A, Foon KA, Whiteside TL, Boyiadzis M (2009) Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia. Clin Cancer Res 15:3325-3332
46. Boschetti G, Nancey S, Sardi F, Roblin X, Flourié B, Kaiserlian D (2011) Therapy with anti-TNFα antibody enhances number and function of Foxp3(+) regulatory T cells in inXammatory bowel diseases. InXamm Bowel Dis 17:160-170
47. Akiyama M, Ichikawa T, Miyaaki H, Motoyoshi Y, Takeshita S, Ozawa E, Miuma S, Shibata H, Taura N, Nakao K (2010) Relationship between regulatory T cells and the combination of pegylated interferon and ribavirin for the treatment of chronic hepatitis type C. Intervirology 53:154-160
48. Campanelli AP, Roselino AM, Cavassani KA, Pereira MS, Mortara RA, Brodskyn CI, Goncalves HS, Belkaid Y, Barral-Netto M, Barral A, Silva JS (2006) CD4+CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells. J Infect Dis 193:1313-1322
49. Gomes-Pereira S, Rodrigues OR, Rolão N, Almeida PD, Santos- Gomes GM (2004) Hepatic cellular immune responses in mice with cure and non-cure phenotype to Leishmania infantum infection: Importance of CD8+ T cells and TGF-beta production. FEMS Immunol Med Microbiol 41:59-68
50. Levings MK, Sangregorio R, Sartirana C, Moschin AL, Battaglia M, Orban PC, Roncarolo MG (2002) Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J Exp Med 196:1335-1346
51. SuYa IJ, Reckling SK, Piccirillo CA, Goldszmid RS, Belkaid Y (2006) Infected site-restricted Foxp3+ natural regulatory T cells are speciWc for microbial antigens. J Exp Med 203:777-788
52. Zheng SG, Wang JH, Stohl W, Kim KS, Gray JD, Horwitz DA (2006) TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells. J Immunol 176:3321-3329
53. Marie JC, Liggitt D, Rudensky AY (2006) Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-speciWc targeting of transforming growth factor-beta receptor. Immunity 25:441-4541
54. Li MO, Sanjabi S, Flavell RA (2006) Transforming growth factorbeta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25:455-471
55. Weng H, Mertens PR, Gressner AM, Dooley S (2007) IFN-gamma abrogates proWbrogenic TGF-beta signaling in liver by targeting expression of inhibitory and receptor Smads. J Hepatol 46:295-303